You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Claims for Patent: 6,514,529

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,514,529

Title:	Oxazolidinone tablet formulation
Abstract:	The present invention provides a compressed tablet of an antibacterial oxazolidinone agent which provides high drug load and excellent bioavailability.
Inventor(s):	Yamamoto; Ken (Portage, MI), Lin; Homer (Oak Park, CA)
Assignee:	Pharmacia & Upjohn Company (Kalamazoo, MI)
Application Number:	09/809,696
Patent Claims:	1. A compressed tablet which contains: 2. A compressed tablet according to claim 1 which contains: 3. A compressed tablet according to claim 1 which contains: 4. A compressed tablet according to claim 3 which contains: 5. A compressed tablet according to claim 1 which contains: 6. A compressed tablet according to claim 5 where: 7. A compressed tablet according to claim 5 where: 8. A compressed tablet according to claim 7 where: 9. A method for providing blood levels of an antibacterial oxazolidinone by oral administration medically equivalent to the blood levels produced by IV administration of the same antibacterial oxazolidinone which comprises administration of a compressed tablet of the formulation: antibacterial oxazolidinone, starch, microcrystalline cellulose, binder selected from the group consisting of hydroxypropylcellulose, hydroxypropylmethylcellulose, povidone and corn starch paste, hydroxypropylcellulose, disintegrants selected from the group consisting of sodium starch glycolate, crosscarmellose sodium, crospovidone and low substituted hydroxypropylcellulose and lubricant selected from the group consisting of stearic acid, metalic salts of stearic acid, hydrogenated vegetable oil and talc. 10. A method according to claim 9 where the antibacterial oxazolidinone is selected from the group consisting of linezolid, eperezolid and (S)-N-[[3-[3-fluoro-4-(tetrahydro-2H-thiopyran-4-yl)phenyl]-2-oxo-5-oxazol idinyl]methyl]acetamide S,S-dioxide. 11. A compressed tablet according to claim 10 where the antibacterial oxazolidinone is selected from the group consisting of linezolid. 12. A method according to claim 11 where the compressed tablet contains: 13. A method according to claim 12 where the compressed tablet contains: 14. A method according to claim 12 where the compressed tablet contains: 15. A method according to claim 14 where the compressed tablet contains: 16. A method according to claim 11 where the compressed tablet contains: 17. A method according to claim 16 where the compressed tablet contains: 18. A method according to claim 16 where the compressed tablet contains: 19. A method according to claim 18 where the compressed tablet contains:

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.